Gary has extensive leadership experience in discovery to late clinical-stage cell and gene therapy and regenerative medicine. He brings deep expertise in product development, operations and translational research, with more than 26 years’ experience in AAV and lentiviral vector biology, manufacturing, and testing. Gary has additional experience in building programs and platforms, due diligence, team management and oversight of contract research organizations, as well as expert-level knowledge of confidentiality agreements, material transfer agreements and work scopes with CROs and collaborators. Gary has published 10 patents and 28 scientific papers, and his scientific opinion on patent submissions is frequently engaged by legal counsel.
Contact us today to learn how our pharma & biotech consulting expertise can serve your project.
Contact us© 2023 Alacrita Holdings Limited | Pharma & Biotech Consulting
Alacrita Consulting
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
One Broadway
Floor 14
Cambridge, MA 02142
Registered in Massachusetts.